YONAL-HINDILERDEN, I. Et Al. 2015. Prognostic significance of asxl1, JAK2V617F mutations and JAK2V617F allele burden in philadelphia-negative myeloproliferative neoplasms. Journal of Blood Medicine , vol.6 , 157-175.

YONAL-HINDILERDEN, I., Daglar-Aday, A., AKADAM-TEKER, B., YILMAZ, C., NALÇACI, M., Yavuz, A. S. , ... SARGIN, D.(2015). Prognostic significance of asxl1, JAK2V617F mutations and JAK2V617F allele burden in philadelphia-negative myeloproliferative neoplasms. Journal of Blood Medicine , vol.6, 157-175.

YONAL-HINDILERDEN, İpek Et Al. "Prognostic significance of asxl1, JAK2V617F mutations and JAK2V617F allele burden in philadelphia-negative myeloproliferative neoplasms," Journal of Blood Medicine , vol.6, 157-175, 2015

YONAL-HINDILERDEN, İpek Y. Et Al. "Prognostic significance of asxl1, JAK2V617F mutations and JAK2V617F allele burden in philadelphia-negative myeloproliferative neoplasms." Journal of Blood Medicine , vol.6, pp.157-175, 2015

YONAL-HINDILERDEN, I. Et Al. (2015) . "Prognostic significance of asxl1, JAK2V617F mutations and JAK2V617F allele burden in philadelphia-negative myeloproliferative neoplasms." Journal of Blood Medicine , vol.6, pp.157-175.

@article{article, author={İpek YÖNAL HİNDİLERDEN Et Al. }, title={Prognostic significance of asxl1, JAK2V617F mutations and JAK2V617F allele burden in philadelphia-negative myeloproliferative neoplasms}, journal={Journal of Blood Medicine}, year=2015, pages={157-175} }